Relative Bioavailability and the Effect of Food on the Bioavailability of LY3023414 in Healthy Subjects

Trial Profile

Relative Bioavailability and the Effect of Food on the Bioavailability of LY3023414 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs LY 3023414 (Primary)
  • Indications Endometrial cancer; Non-small cell lung cancer; Prostate cancer; Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 03 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 06 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 09 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top